| Code | Description | Claims | Beneficiaries | Total Paid |
| T1015 |
Clinic visit/encounter, all-inclusive |
74,238 |
66,508 |
$6.13M |
| 00003 |
Internal/system code - not a standard HCPCS code |
12,897 |
9,916 |
$3.38M |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
535,378 |
486,182 |
$2.95M |
| 59425 |
|
32,388 |
22,934 |
$1.63M |
| 90832 |
Psychotherapy, 30 minutes with patient |
25,269 |
19,602 |
$1.12M |
| 99212 |
Office or other outpatient visit for the evaluation and management of an established patient, straightforward |
75,468 |
69,026 |
$430K |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
48,638 |
45,362 |
$426K |
| 99203 |
Office or other outpatient visit for the evaluation and management of a new patient, low complexity |
8,820 |
8,750 |
$231K |
| 90791 |
Psychiatric diagnostic evaluation |
2,087 |
2,034 |
$198K |
| 96110 |
Developmental screening, with scoring and documentation, per standardized instrument |
15,458 |
14,976 |
$168K |
| 99000 |
|
191,826 |
177,716 |
$159K |
| 92551 |
|
22,085 |
21,226 |
$153K |
| 92552 |
|
13,711 |
13,421 |
$147K |
| 99392 |
Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) |
22,831 |
22,493 |
$131K |
| 99393 |
Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) |
17,576 |
17,228 |
$103K |
| 99391 |
Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) |
10,100 |
9,816 |
$93K |
| G0467 |
Federally qualified health center (fqhc) visit, established patient; a medically-necessary, face-to-face encounter (one-on-one) between an established patient and a fqhc practitioner during which time one or more fqhc services are rendered and includes a typical bundle of medicare-covered services that would be furnished per diem to a patient receiving a fqhc visit |
4,246 |
3,673 |
$84K |
| 99394 |
Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) |
12,757 |
12,410 |
$77K |
| 90834 |
Psychotherapy, 45 minutes with patient |
1,475 |
1,187 |
$70K |
| 90792 |
Psychiatric diagnostic evaluation with medical services |
546 |
544 |
$68K |
| 90651 |
|
3,604 |
3,468 |
$64K |
| 99215 |
Prolong outpt/office vis |
645 |
643 |
$62K |
| 90471 |
Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine |
65,475 |
63,833 |
$53K |
| 59409 |
Vaginal delivery only (with or without episiotomy and/or forceps) |
93 |
93 |
$49K |
| 90686 |
|
19,204 |
18,766 |
$42K |
| 90670 |
|
4,284 |
4,221 |
$42K |
| 90472 |
Immunization administration, each additional vaccine (list separately) |
13,878 |
13,566 |
$34K |
| 81003 |
|
36,313 |
29,670 |
$32K |
| 88141 |
|
552 |
239 |
$28K |
| 99395 |
Periodic comprehensive preventive medicine reevaluation, established patient, 18-39 years |
2,909 |
2,821 |
$27K |
| 90715 |
|
2,394 |
2,344 |
$27K |
| G0447 |
Face-to-face behavioral counseling for obesity, 15 minutes |
9,019 |
8,802 |
$26K |
| 92004 |
Ophthalmological services: medical examination and evaluation, comprehensive, new patient |
678 |
667 |
$24K |
| 99205 |
Prolong outpt/office vis |
137 |
135 |
$23K |
| G9012 |
Other specified case management service not elsewhere classified |
6,065 |
4,882 |
$23K |
| 99202 |
Office or other outpatient visit for the evaluation and management of a new patient, straightforward |
1,726 |
1,675 |
$22K |
| H1003 |
Prenatal care, at-risk enhanced service; education |
4,601 |
4,041 |
$22K |
| H2000 |
Comprehensive multidisciplinary evaluation |
240 |
233 |
$21K |
| 59430 |
|
408 |
397 |
$21K |
| 86328 |
|
515 |
514 |
$21K |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
5,954 |
5,497 |
$20K |
| 90739 |
|
415 |
411 |
$19K |
| 90460 |
Immunization administration through 18 years of age via any route, first or only component |
5,923 |
5,892 |
$16K |
| 98940 |
|
1,954 |
1,121 |
$15K |
| 98941 |
Chiropractic manipulative treatment; spinal, 3-4 regions |
1,583 |
900 |
$15K |
| 81025 |
|
8,839 |
8,459 |
$10K |
| 90461 |
|
1,916 |
1,907 |
$10K |
| 93000 |
|
1,043 |
1,016 |
$10K |
| 99242 |
|
219 |
215 |
$9K |
| 99381 |
|
236 |
219 |
$9K |
| 90750 |
|
65 |
64 |
$9K |
| 99396 |
Periodic comprehensive preventive medicine reevaluation, established patient, 40-64 years |
2,945 |
2,894 |
$9K |
| 90710 |
|
1,135 |
1,133 |
$8K |
| 99385 |
|
123 |
112 |
$8K |
| 87811 |
Infectious agent antigen detection by immunoassay; SARS-CoV-2 (COVID-19) |
843 |
828 |
$8K |
| 99204 |
Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity |
912 |
908 |
$7K |
| 90723 |
|
1,524 |
1,519 |
$6K |
| 99383 |
|
575 |
469 |
$6K |
| 90734 |
|
1,316 |
1,304 |
$6K |
| 92015 |
Determination of refractive state |
814 |
801 |
$6K |
| 83036 |
Hemoglobin; glycosylated (A1C) |
17,812 |
17,438 |
$6K |
| 99201 |
|
289 |
287 |
$6K |
| 90716 |
|
547 |
546 |
$6K |
| 85018 |
|
24,473 |
23,810 |
$5K |
| 83655 |
|
5,044 |
4,985 |
$5K |
| 99401 |
|
5,773 |
5,634 |
$5K |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
2,693 |
2,673 |
$5K |
| 90677 |
|
463 |
455 |
$4K |
| J3490 |
Unclassified drugs |
133 |
133 |
$4K |
| 11721 |
|
444 |
433 |
$4K |
| 86580 |
|
1,806 |
1,756 |
$4K |
| 90633 |
|
3,052 |
3,014 |
$4K |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
5,379 |
5,263 |
$4K |
| 90688 |
|
884 |
874 |
$4K |
| 90681 |
|
555 |
549 |
$3K |
| 90707 |
|
375 |
374 |
$3K |
| 94640 |
Pressurized or nonpressurized inhalation treatment for acute airway obstruction |
2,037 |
1,935 |
$3K |
| 90473 |
|
704 |
704 |
$3K |
| 71046 |
Radiologic examination, chest; 2 views |
1,146 |
1,123 |
$3K |
| 99384 |
|
83 |
82 |
$3K |
| 99460 |
|
148 |
118 |
$3K |
| 99238 |
Hospital discharge day management, 30 minutes or less |
206 |
163 |
$2K |
| 90696 |
|
551 |
547 |
$2K |
| 81000 |
|
850 |
629 |
$2K |
| 99173 |
|
17,529 |
17,039 |
$2K |
| 0012A |
|
130 |
97 |
$2K |
| 99382 |
|
47 |
45 |
$2K |
| 0064A |
|
46 |
46 |
$2K |
| 90620 |
|
420 |
411 |
$2K |
| 90648 |
|
1,353 |
1,349 |
$2K |
| 0011A |
|
90 |
59 |
$2K |
| 90697 |
|
1,020 |
957 |
$2K |
| G9008 |
Coordinated care fee, physician coordinated care oversight services |
7,732 |
5,365 |
$2K |
| 99188 |
|
687 |
545 |
$2K |
| 20610 |
|
44 |
42 |
$1K |
| 72081 |
|
68 |
68 |
$1K |
| 97803 |
|
339 |
322 |
$1K |
| G2023 |
Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source |
300 |
298 |
$1K |
| 57410 |
|
120 |
119 |
$1K |
| 90700 |
|
532 |
531 |
$1K |
| 96160 |
|
48,760 |
47,327 |
$1K |
| S9445 |
Patient education, not otherwise classified, non-physician provider, individual, per session |
175 |
161 |
$1K |
| 81002 |
|
574 |
514 |
$1K |
| 90837 |
Psychotherapy, 53 minutes with patient |
463 |
367 |
$1K |
| 90647 |
|
1,119 |
1,114 |
$790.96 |
| G9920 |
Screening performed and negative |
1,030 |
1,013 |
$754.01 |
| G2025 |
Payment for a telehealth distant site service furnished by a rural health clinic (rhc) or federally qualified health center (fqhc) only |
90 |
83 |
$644.39 |
| 72080 |
|
33 |
33 |
$596.64 |
| 72100 |
|
229 |
229 |
$529.58 |
| 82948 |
|
5,100 |
4,488 |
$393.75 |
| 0031A |
|
45 |
45 |
$369.07 |
| 73630 |
|
267 |
261 |
$343.98 |
| 99442 |
|
565 |
544 |
$335.75 |
| 73562 |
|
190 |
187 |
$331.50 |
| 90674 |
|
14 |
14 |
$289.64 |
| G8510 |
Screening for depression is documented as negative, a follow-up plan is not required |
99,772 |
90,876 |
$233.75 |
| 99462 |
|
28 |
17 |
$219.92 |
| J7626 |
Budesonide, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose form, up to 0.5 mg |
927 |
890 |
$215.75 |
| 36415 |
Collection of venous blood by venipuncture |
48,330 |
46,013 |
$189.89 |
| 73610 |
|
173 |
170 |
$183.37 |
| J1885 |
Injection, ketorolac tromethamine, per 15 mg |
988 |
933 |
$150.03 |
| J3301 |
Injection, triamcinolone acetonide, not otherwise specified, 10 mg |
57 |
54 |
$140.16 |
| 73130 |
|
82 |
81 |
$114.94 |
| 96127 |
|
204 |
194 |
$90.44 |
| 90713 |
|
45 |
40 |
$89.55 |
| 73030 |
|
38 |
38 |
$86.30 |
| 96111 |
|
13 |
13 |
$67.29 |
| J1100 |
Injection, dexamethasone sodium phosphate, 1 mg |
2,468 |
2,350 |
$66.04 |
| 80307 |
Drug test(s), presumptive, any number of drug classes; immunoassay |
117 |
111 |
$63.21 |
| 90672 |
|
115 |
115 |
$62.06 |
| 86803 |
|
1,005 |
977 |
$61.33 |
| 90662 |
|
35 |
35 |
$51.35 |
| 90619 |
|
964 |
922 |
$42.00 |
| 87491 |
Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe |
1,826 |
1,627 |
$30.86 |
| J0696 |
Injection, ceftriaxone sodium, per 250 mg |
544 |
506 |
$29.67 |
| 96150 |
|
409 |
408 |
$17.85 |
| 84403 |
|
215 |
198 |
$16.83 |
| 99211 |
Office or other outpatient visit for the evaluation and management of an established patient, minimal severity |
4,002 |
3,939 |
$12.00 |
| 87086 |
Culture, bacterial; quantitative colony count, urine |
1,441 |
1,384 |
$10.21 |
| 85025 |
Blood count; complete (CBC), automated, and automated differential WBC count |
14,399 |
14,140 |
$9.95 |
| 80053 |
Comprehensive metabolic panel |
17,869 |
17,538 |
$9.95 |
| 99441 |
|
626 |
617 |
$9.46 |
| J7620 |
Albuterol, up to 2.5 mg and ipratropium bromide, up to 0.5 mg, fda-approved final product, non-compounded, administered through dme |
554 |
525 |
$8.68 |
| 81001 |
|
2,633 |
2,516 |
$8.25 |
| 84443 |
Thyroid stimulating hormone (TSH) |
11,180 |
10,952 |
$6.93 |
| 80061 |
Lipid panel |
15,594 |
15,174 |
$6.93 |
| J7614 |
Levalbuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose, 0.5 mg |
868 |
832 |
$6.92 |
| 85610 |
|
59 |
58 |
$6.92 |
| J2930 |
Injection, methylprednisolone sodium succinate, up to 125 mg |
184 |
165 |
$6.09 |
| 85027 |
|
707 |
691 |
$5.00 |
| 86592 |
|
1,384 |
1,346 |
$3.80 |
| J3420 |
Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg |
35 |
26 |
$2.86 |
| J8540 |
Dexamethasone, oral, 0.25 mg |
214 |
214 |
$2.09 |
| J7611 |
Albuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, concentrated form, 1 mg |
76 |
76 |
$0.14 |
| S9470 |
Nutritional counseling, dietitian visit |
3,104 |
2,853 |
$0.01 |
| 3351F |
|
10,672 |
9,615 |
$0.00 |
| 36416 |
|
237 |
236 |
$0.00 |
| 1000F |
|
863 |
809 |
$0.00 |
| 82306 |
Vitamin D; 25 hydroxy, includes fraction(s), if performed |
8,839 |
8,709 |
$0.00 |
| 86695 |
|
27 |
27 |
$0.00 |
| 82043 |
|
1,561 |
1,533 |
$0.00 |
| 3074F |
|
823 |
787 |
$0.00 |
| 1031F |
|
12,548 |
12,004 |
$0.00 |
| 87536 |
|
266 |
217 |
$0.00 |
| 87389 |
Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies |
4,421 |
4,338 |
$0.00 |
| 1220F |
|
6,987 |
6,467 |
$0.00 |
| 82607 |
|
1,444 |
1,438 |
$0.00 |
| H0033 |
Oral medication administration, direct observation |
1,730 |
1,667 |
$0.00 |
| 99443 |
|
90 |
68 |
$0.00 |
| 4000F |
|
410 |
375 |
$0.00 |
| 83550 |
|
210 |
209 |
$0.00 |
| 87624 |
Infectious agent detection by nucleic acid; human papillomavirus (HPV), high-risk types |
741 |
733 |
$0.00 |
| 4060F |
|
478 |
342 |
$0.00 |
| 87591 |
Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe |
222 |
222 |
$0.00 |
| 87340 |
|
750 |
732 |
$0.00 |
| 80048 |
Basic metabolic panel (calcium, ionized) |
106 |
105 |
$0.00 |
| 82105 |
|
58 |
57 |
$0.00 |
| Z1034 |
|
128 |
104 |
$0.00 |
| 86706 |
|
321 |
314 |
$0.00 |
| 3079F |
|
351 |
341 |
$0.00 |
| 82670 |
|
165 |
156 |
$0.00 |
| V5008 |
Hearing screening |
36 |
36 |
$0.00 |
| 3075F |
|
161 |
158 |
$0.00 |
| 82728 |
|
239 |
238 |
$0.00 |
| 2001F |
|
339 |
303 |
$0.00 |
| 90680 |
|
62 |
62 |
$0.00 |
| 97802 |
|
188 |
166 |
$0.00 |
| J2920 |
Injection, methylprednisolone sodium succinate, up to 40 mg |
17 |
17 |
$0.00 |
| 86850 |
|
58 |
57 |
$0.00 |
| 84402 |
|
120 |
107 |
$0.00 |
| 3080F |
|
61 |
61 |
$0.00 |
| 84153 |
|
216 |
206 |
$0.00 |
| J0456 |
Injection, azithromycin, 500 mg |
100 |
99 |
$0.00 |
| 85652 |
|
92 |
92 |
$0.00 |
| G9275 |
Documentation that patient is a current non-tobacco user |
125 |
120 |
$0.00 |
| D1330 |
|
13 |
13 |
$0.00 |
| 87081 |
|
37 |
34 |
$0.00 |
| 87522 |
Neg quan hep c or qual rna |
80 |
76 |
$0.00 |
| A9150 |
Non-prescription drugs |
16 |
16 |
$0.00 |
| 3008F |
|
13 |
13 |
$0.00 |
| J2001 |
Injection, lidocaine hcl for intravenous infusion, 10 mg |
44 |
43 |
$0.00 |
| J0561 |
Injection, penicillin g benzathine, 100,000 units |
30 |
30 |
$0.00 |
| 86361 |
|
100 |
88 |
$0.00 |
| 1034F |
|
113 |
108 |
$0.00 |
| 91301 |
|
73 |
73 |
$0.00 |
| A7015 |
Aerosol mask, used with dme nebulizer |
107 |
107 |
$0.00 |
| 88150 |
|
41 |
40 |
$0.00 |
| 84478 |
|
47 |
47 |
$0.00 |
| 91315 |
|
31 |
28 |
$0.00 |
| 91305 |
|
33 |
33 |
$0.00 |
| 91307 |
|
26 |
26 |
$0.00 |
| 90480 |
|
69 |
68 |
$0.00 |
| 87070 |
|
84 |
82 |
$0.00 |
| 94760 |
|
12 |
12 |
$0.00 |
| 82950 |
|
71 |
70 |
$0.00 |
| 91319 |
|
14 |
14 |
$0.00 |
| 86593 |
|
12 |
12 |
$0.00 |
| H0049 |
Alcohol and/or drug screening |
33 |
33 |
$0.00 |
| Z6410 |
|
34 |
29 |
$0.00 |
| G9800 |
Patients who are identified as having an intolerance or allergy to beta-blocker therapy |
13 |
13 |
$0.00 |
| Z1032 |
|
13 |
13 |
$0.00 |
| 1111F |
|
12 |
12 |
$0.00 |
| 99001 |
|
183 |
177 |
$0.00 |
| 80074 |
|
721 |
715 |
$0.00 |
| G8431 |
Screening for depression is documented as being positive and a follow-up plan is documented |
920 |
888 |
$0.00 |
| J8499 |
Prescription drug, oral, non chemotherapeutic, nos |
90 |
85 |
$0.00 |
| 3078F |
|
859 |
823 |
$0.00 |
| 83525 |
|
201 |
200 |
$0.00 |
| 82274 |
|
237 |
234 |
$0.00 |
| 86765 |
|
363 |
363 |
$0.00 |
| 84439 |
|
995 |
978 |
$0.00 |
| 99423 |
|
157 |
129 |
$0.00 |
| 86038 |
|
29 |
25 |
$0.00 |
| 90685 |
|
41 |
41 |
$0.00 |
| 1033F |
|
195 |
190 |
$0.00 |
| 3077F |
|
238 |
224 |
$0.00 |
| 86787 |
|
349 |
349 |
$0.00 |
| 87799 |
|
327 |
324 |
$0.00 |
| 80076 |
|
28 |
28 |
$0.00 |
| 87481 |
|
184 |
176 |
$0.00 |
| G8483 |
Influenza immunization was not administered for reasons documented by clinician (e.g., patient allergy or other medical reasons, patient declined or other patient reasons, vaccine not available or other system reasons) |
226 |
220 |
$0.00 |
| 99499 |
|
44 |
44 |
$0.00 |
| 2028F |
|
88 |
88 |
$0.00 |
| 4004F |
|
784 |
778 |
$0.00 |
| 90749 |
|
47 |
47 |
$0.00 |
| 73140 |
|
26 |
26 |
$0.00 |
| 86360 |
|
33 |
28 |
$0.00 |
| 84450 |
|
71 |
68 |
$0.00 |
| 84460 |
|
71 |
68 |
$0.00 |
| 69210 |
|
76 |
73 |
$0.00 |
| 99051 |
|
27 |
26 |
$0.00 |
| 81220 |
CFTR (cystic fibrosis transmembrane conductance regulator) gene analysis; common variants |
13 |
13 |
$0.00 |
| 84481 |
|
138 |
133 |
$0.00 |
| G0444 |
Annual depression screening, 5 to 15 minutes |
41 |
37 |
$0.00 |
| 0124A |
|
28 |
27 |
$0.00 |
| 86735 |
|
30 |
30 |
$0.00 |
| 0054A |
|
18 |
18 |
$0.00 |
| 87338 |
|
45 |
44 |
$0.00 |
| 91312 |
|
63 |
59 |
$0.00 |
| 73110 |
|
35 |
34 |
$0.00 |
| 91320 |
|
14 |
14 |
$0.00 |
| 96158 |
|
13 |
13 |
$0.00 |
| 86480 |
|
16 |
16 |
$0.00 |
| 90649 |
|
21 |
21 |
$0.00 |
| 90756 |
|
29 |
29 |
$0.00 |
| 0502F |
|
13 |
12 |
$0.00 |
| 88175 |
Cytopathology, cervical or vaginal, any reporting system; collected in preservative fluid, automated thin layer |
12 |
12 |
$0.00 |
| S0613 |
Annual gynecological examination; clinical breast examination without pelvic evaluation |
12 |
12 |
$0.00 |
| 90746 |
|
13 |
13 |
$0.00 |
| S0197 |
Prenatal vitamins, 30-day supply |
17 |
17 |
$0.00 |
| 92550 |
|
12 |
12 |
$0.00 |